Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Minority Interest (2024 - 2026)

Usana Health Sciences has reported Minority Interest over the past 3 years, most recently at $51.2 million for Q2 2026.

  • Quarterly Minority Interest fell 5.31% to $51.2 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $51.2 million through Apr 2026, down 5.31% year-over-year, with the annual reading at $53.2 million for FY2026, 1.95% down from the prior year.
  • Minority Interest was $51.2 million for Q2 2026 at Usana Health Sciences, down from $53.2 million in the prior quarter.
  • Over five years, Minority Interest peaked at $54.5 million in Q2 2025 and troughed at $51.2 million in Q2 2026.
  • The 3-year median for Minority Interest is $53.8 million (2025), against an average of $53.5 million.
  • The largest YoY upside for Minority Interest was 1.95% in 2026 against a maximum downside of 5.31% in 2026.
  • A 3-year view of Minority Interest shows it stood at $54.2 million in 2024, then fell by 1.37% to $53.5 million in 2025, then dropped by 4.19% to $51.2 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Minority Interest are $51.2 million (Q2 2026), $53.2 million (Q1 2026), and $53.5 million (Q3 2025).